Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2021-02-16 4:39 pm Sale | 13G | PREVAIL THERAPEUTICS INC PRVL | RA CAPITAL MANAGEMENT L.P. | 0 0% | -3,363,605 (Position Closed) | View |
| 2021-02-16 4:30 pm Purchase | 13G | PREVAIL THERAPEUTICS INC PRVL | CITADEL ADVISORS LLC | 2,421,024 7.1% | 7,143 (+0.30%) | View |
| 2021-02-12 4:19 pm Sale | 13G | PREVAIL THERAPEUTICS INC PRVL | REGENXBIO Inc. RGNX | 0 0% | -2,030,000 (Position Closed) | View |
| 2021-02-12 4:06 pm Sale | 13G | PREVAIL THERAPEUTICS INC PRVL | EcoR1 Capital LLC | 0 0% | -2,248,306 (Position Closed) | View |
| 2021-01-29 4:15 pm Unchanged | 13G | PREVAIL THERAPEUTICS INC PRVL | JNE Partners LLP | 0 0% | 0 (Unchanged) | View |
| 2021-01-28 8:30 pm Sale | 13D | PREVAIL THERAPEUTICS INC PRVL | ORBIMED ADVISORS LLC | 0 0% | -13,822,463 (Position Closed) | View |
| 2020-12-22 08:49 am Purchase | 13D | PREVAIL THERAPEUTICS INC PRVL | ELI LILLY & Co LLY | 18,858,511 53.3% | 18,858,511 (New Position) | View |
| 2020-10-08 4:02 pm Purchase | 13G | PREVAIL THERAPEUTICS INC PRVL | CITADEL ADVISORS LLC | 2,413,881 7.1% | 2,413,881 (New Position) | View |
| 2020-02-14 4:34 pm Purchase | 13G | PREVAIL THERAPEUTICS INC PRVL | RA CAPITAL MANAGEMENT L.P. | 3,363,605 9.9% | 3,363,605 (New Position) | View |
| 2020-02-14 2:38 pm Sale | 13G | PREVAIL THERAPEUTICS INC PRVL | EcoR1 Capital LLC | 2,248,306 6.6% | -144,250 (-6.03%) | View |
| 2020-02-13 5:12 pm Purchase | 13G | PREVAIL THERAPEUTICS INC PRVL | Abeliovich Asa | 2,988,428 8.6% | 2,988,428 (New Position) | View |
| 2020-02-13 4:29 pm Purchase | 13G | PREVAIL THERAPEUTICS INC PRVL | REGENXBIO Inc. RGNX | 2,030,000 5.95% | 2,030,000 (New Position) | View |
| 2019-06-28 4:17 pm Purchase | 13G | PREVAIL THERAPEUTICS INC PRVL | EcoR1 Capital LLC | 2,392,556 7% | 2,392,556 (New Position) | View |
| 2019-06-27 1:20 pm Purchase | 13D | PREVAIL THERAPEUTICS INC PRVL | ORBIMED ADVISORS LLC | 13,822,463 40.7% | 13,822,463 (New Position) | View |